Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03292887 · ClinicalTrials.gov registry record
Hunter Outcome Survey (HOS)
A clinical trial of Hunter Syndrome, sponsored by Shire.
- Completed
- Registry status
- 1,443
- Enrollment target
- 1
- Study location
NCT03292887 is a study of Hunter Syndrome that has completed, run by Shire. The registered enrollment target is 1,443 participants, above the 68-participant average among 5 other Hunter Syndrome trials with a reported enrollment target (2022% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03292887, a study of Hunter Syndrome, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- 1,443 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data that will increase understanding of Hunter syndrome. The data from HOS may provide guidance to healthcare professionals about disease treatment options.
Conditions Studied
Study Locations (1)
Massachusetts
- Shire - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,443 participants |
| Start Date | 2005-10-03 |
| Est. Completion | 2023-02-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03292887
The ClinicalTrials.gov registry entry for NCT03292887 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,443 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 68-participant average among 5 other Hunter Syndrome trials with a reported enrollment target (2022% higher). The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hunter Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03292887 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03292887 about?
NCT03292887 is a clinical study titled "Hunter Outcome Survey (HOS)". The purpose of this study is to collect data that will increase understanding of Hunter syndrome. The data from HOS may provide guidance to healthcare professionals about disease treatment options.
What is the current status of trial NCT03292887?
This trial is currently completed. The enrollment target is 1,443 participants. The study started on 2005-10-03. Estimated completion is 2023-02-16.
What conditions does trial NCT03292887 study?
This clinical trial studies the following conditions: Hunter Syndrome.
Who is sponsoring clinical trial NCT03292887?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03292887 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hunter Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
ACTIVE NOT RECRUITING · Phase 2
-
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment
COMPLETED · Phase 1
-
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
COMPLETED · Phase 1
-
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
COMPLETED · Phase 2
-
Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.